TLR2‐Driven NLRP3 Inflammasome Activation Mediates EV71‐Induced Neuropathogenesis in Neonatal Mice
Journal of Medical Virology · 2026
DOI: 10.1002/jmv.71015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Yingyu Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Jiamusi University of Basic Medicine, Jiamusi University, Jiamusi, Heilongjiang, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Toll-Like Receptor 2, Inflammasomes, Enterovirus A, Human. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Heilongjiang Provincial Natural Science Foundation of China, Fundamental Research Funds for Provincial Universities of Heilongjiang Province, Key Science and Technology Project of Jiamusi University.
Abstract (Originalsprache)
EV71 is a leading cause of HFMD‐associated neurological complications, yet its CNS pathogenic mechanisms remain unclear. Using neonatal BALB/c mice, we identified 10 days post‐infection (dpi) as the disease peak, characterized by neuronal necrosis and robust NLRP3 inflammasome activation. We demonstrate that EV71 upregulates TLR2, triggering the NF‐κB pathway to prime and activate the NLRP3 inflammasome within microglia. This process drives pro‐inflammatory cytokine release and neuroinflammatory damage. Pharmacological blockade of TLR2 with C29 suppressed NF‐κB phosphorylation and NLRP3 assembly, reducing viral accumulation by improving the neuroinflammatory microenvironment rather than through direct antiviral activity. Furthermore, the NLRP3 inhibitor MCC950 significantly attenuated clinical symptoms, reduced neuronal apoptosis, and improved survival rates. In summary, our findings identify the TLR2–NF‐κB–NLRP3 signaling axis as a central driver of EV71‐induced neuroinflammation. This cascade represents a promising host‐directed therapeutic target for mitigating the neurological sequelae associated with EV71 infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiamusi University of Basic Medicine, Jiamusi University, Jiamusi, Heilongjiang, China.
- Xuzhou Medical University, Xuzhou, Jiangsu, China.
ORCID-Profile: Rui Wu
Förderung
- Heilongjiang Provincial Natural Science Foundation of China
- Fundamental Research Funds for Provincial Universities of Heilongjiang Province
- Key Science and Technology Project of Jiamusi University
- Startup Project of the Doctoral Special Research Fund of Jiamusi University
- "East Pole" Research Team of Jiamusi University
- Oral Biomedical Materials R&D and Personalized Manufacturing Characteristic Discipline Project of Heilongjiang Province
Zitieren
APA
Li, Y., Liu, T., Li, Y., Zhang, X., Dai, J., Zhang, J., Wang, B., Liu, L., & Wu, R. (2026). TLR2‐Driven NLRP3 Inflammasome Activation Mediates EV71‐Induced Neuropathogenesis in Neonatal Mice. Journal of Medical Virology. https://doi.org/10.1002/jmv.71015
Vancouver
Li Y, Liu T, Li Y, Zhang X, Dai J, Zhang J, et al. TLR2‐Driven NLRP3 Inflammasome Activation Mediates EV71‐Induced Neuropathogenesis in Neonatal Mice. Journal of Medical Virology. 2026. doi:10.1002/jmv.71015
BibTeX
@article{Li2026,
author = {Li, Yingyu and Liu, Tianrun and Li, Yao and Zhang, Xiaomeng and Dai, Junfei and Zhang, Jialin and Wang, Baixin and Liu, Lei and Wu, Rui},
title = {TLR2‐Driven NLRP3 Inflammasome Activation Mediates EV71‐Induced Neuropathogenesis in Neonatal Mice},
journal = {Journal of Medical Virology},
year = {2026},
doi = {10.1002/jmv.71015}
}
EUVIMED